4.5 Review

Base resolution methylome profiling: considerations in platform selection, data preprocessing and analysis

期刊

EPIGENOMICS
卷 7, 期 5, 页码 813-828

出版社

FUTURE MEDICINE LTD
DOI: 10.2217/epi.15.21

关键词

bisulfite sequencing; differential methylation; DNA methylation; methylation 450K array; normalization; reduced representation bisulfite sequencing; study design

资金

  1. Division of Biomedical Statistics and Informatics Meritorious Award
  2. Mayo Clinic Center for Individualized Medicine
  3. National Cancer Institute [NCI R01CA118444]

向作者/读者索取更多资源

Bisulfite treatment-based methylation microarray (mainly Illumina 450K Infinium array) and next-generation sequencing (reduced representation bisulfite sequencing, Agilent SureSelect Human Methyl-Seq, NimbleGen SeqCap Epi CpGiant or whole-genome bisulfite sequencing) are commonly used for base resolution DNA methylome research. Although multiple tools and methods have been developed and used for the data preprocessing and analysis, confusions remains for these platforms including how and whether the 450k array should be normalized; which platform should be used to better fit researchers' needs; and which statistical models would be more appropriate for differential methylation analysis. This review presents the commonly used platforms and compares the pros and cons of each in methylome profiling. We then discuss approaches to study design, data normalization, bias correction and model selection for differentially methylated individual CpGs and regions.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据